Trends of ciprofloxacin use in Kazakhstan, impacts of COVID-19, and strategies for AMR control
Kussainova A. Kassym L. Aljofan M. Akhmetova K. Derbissalina G. Bekbergenova Z. Uzbekova S. Botabayeva A. Semenova Y.
December 2025Nature Research
Scientific Reports
2025#15Issue 1
The misuse of antibacterial agents is a key driver of the rapid and widespread rise in antimicrobial resistance (AMR). This study examines the consumption trends of ciprofloxacin—the second most consumed antibiotic in Kazakhstan across outpatient and inpatient settings—before, during, and after the COVID-19 pandemic to inform AMR mitigation strategies. The analysis is based on two data sources: a comprehensive review of national regulatory documents governing ciprofloxacin use and a pharmaco-epidemiological assessment of procurement data provided by Vi-ORTIS. Ciprofloxacin consumption (ATC group J01MA02) from 2017 to 2023 was quantified in DDD/1000 inhabitants/day (DID) via the ATC/DDD methodology. Only 16 of 50 recommendations in national protocols align with the ciprofloxacin prescribing guidelines established in international standards. During the pandemic, ciprofloxacin use increased, with total and outpatient consumption peaking in the third quarter of 2020, whereas inpatient consumption peaked earlier in the second quarter. In the post pandemic period, inpatient consumption steadily declined, reaching 0.06 DID in 2023. The persistent increase in the use of “Watch” antibiotics, including ciprofloxacin, has raised concerns for Kazakhstan’s healthcare system. Strengthening antimicrobial stewardship programs, implementing targeted interventions, and enhancing surveillance efforts are essential to curbing antibiotic overuse and safeguarding public health.
Antimicrobial resistance , Ciprofloxacin , COVID-19 , Fluoroquinolones , Kazakhstan
Text of the article Перейти на текст статьи
Department of General Medical Practice with a Course of Evidence-Based Medicine, Astana Medical University, Astana, Kazakhstan
School of Medicine, Nazarbayev University, 53 Kabanbay Batyr Ave., Astana, 010000, Kazakhstan
Department of Public Health, Astana Medical University, Astana, Kazakhstan
School of Medicine, Semey Medical University, Semey, Kazakhstan
Department of Internal Medicine and Rheumatology, Semey Medical University, Semey, Kazakhstan
Department of General Medical Practice with a Course of Evidence-Based Medicine
School of Medicine
Department of Public Health
School of Medicine
Department of Internal Medicine and Rheumatology
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026